我们如何治疗严重的遗传性抗血素缺乏症:从布达佩斯3变种的同卵性病例中吸取教训
Carlos Bravo-Pérez1, Javier Corral1, Christelle Orlando2
1Department of Hematology, Hospital Universitario Morales Meseguer, University of Murcia, Instituto Murciano de Investigacion Biosanitaria (IMIB)-Pascual Parrilla, Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER)-Instituto de Salud Carlos III, Murcia, Spain.
Journal of thrombosis and haemostasis : JTH
|February 11, 2025
概括
抗血缺乏症,一种严重的遗传血,经常被低估. 这项研究突出了严重病例的临床特征和管理,包括同卵性抗血布达佩斯3变体.
科学领域:
- 血液学 血液学 血液学
- 遗传学 是一个遗传学.
- 血栓友爱症 (Thrombophilia) 是一种发生血栓友爱症的疾病.
背景情况:
- 抗素缺乏症是一种严重的遗传性血栓性病,由于诊断限制和临床变异性,经常被诊断不足.
- I型变异导致严重的血栓友,而II型变异,特别是氨酸结合部位缺陷,如Antithrombin Budapest 3,更为常见和异质.
- 同性合体抗血布达佩斯3个体显著存在,特别是在罗马人群中.
研究的目的:
- 确定严重抗血素缺乏症的临床特征,诊断方法和管理策略.
- 调查 homozygous Antithrombin Budapest 3 的病例,以了解这种疾病的范围和挑战.
主要方法:
- 分析了25年来从西班牙,比利时和匈牙利中心招募的699名抗血素缺乏症患者.
- 专注于 homozygous Antithrombin Budapest 3 的两个说明案例.
主要成果:
- 同卵性抗血栓布达佩斯3例患者表现出非常低的抗血栓活性 (<20%) 并存在青少年复发性静脉血栓栓塞.
- 管理挑战包括肝素耐药性,静脉异常和产科并发症,往往缺乏基于证据的指导方针.
结论:
- 制定了专家建议,以管理抗血素缺乏的复杂情景.
- 讨论了这种罕见但严重的血栓友爱症的未来研究前景.
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
601
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
601
01:19X-linked Traits
53.0K
In most mammalian species, females have two X sex chromosomes and males have an X and Y. As a result, mutations on the X chromosome in females may be masked by the presence of a normal allele on the second X. In contrast, a mutation on the X chromosome in males more often causes observable biological defects, as there is no normal X to compensate. Trait variations arising from mutations on the X chromosome are called “X-linked”.
53.0K
01:35Pedigree Analysis
83.7K
Overview
83.7K
01:24Disorders of Hemostasis
686
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
686
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
131
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
131
02:45Blood Transfusion and Agglutination
10.7K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
10.7K